Compare OPK & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPK | LZB |
|---|---|---|
| Founded | 2006 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2011 | 1994 |
| Metric | OPK | LZB |
|---|---|---|
| Price | $1.66 | $30.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $4.15 | ★ $41.00 |
| AVG Volume (30 Days) | ★ 3.8M | 519.1K |
| Earning Date | 11-04-2026 | 11-17-2026 |
| Dividend Yield | N/A | ★ 3.29% |
| EPS Growth | N/A | ★ 5.11 |
| EPS | N/A | ★ N/A |
| Revenue | $606,879,000.00 | ★ $2,349,433,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.09 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.98 | $28.39 |
| 52 Week High | $1.77 | $44.90 |
| Indicator | OPK | LZB |
|---|---|---|
| Relative Strength Index (RSI) | 58.74 | 51.74 |
| Support Level | $1.10 | $28.59 |
| Resistance Level | $1.75 | $30.84 |
| Average True Range (ATR) | 0.09 | 0.76 |
| MACD | 0.01 | 0.18 |
| Stochastic Oscillator | 74.47 | 78.78 |
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
La-Z-Boy Inc is a world'wide producer of reclining chairs and one of the manufacturers/distributors of residential furniture in the United States. It manufacture, market, import, export, distribute and retail upholstery furniture products. In addition, it import, distribute and retail accessories and casegoods (wood) furniture products. Its reportable operating segments include the Retail segment and the Wholesale segment. Its Retail segment mainly sells upholstered furniture. Wholesale segment manufactures and imports upholstered and casegoods (wood) furniture and sells directly. The company generates majority of revenue from Wholesale segment which manufactures and imports upholstered furniture, such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, etc.